Indian Diabetes Diagnosis and Therapeutics Market: Industry Growth, Size, Share and Forecast 2019-2025

1. Orion Market Research Indian Diabetes Diagnosis and Therapeutics Market, by Disease Type (Type 1 Diabetes, Type 2 Diabetes, Gestational), By Drug Type (Oral anti-diabetic Drugs, Non-Insulin Injectable drugs, Combination Drugs), by Device Type (Blood Glucose Monitoring Devices, Blood Glucose Strips, Insulin devices, Others) - Global Trends, Size, Share, Growth, Industry Analysis and Forecast, 2019-2025 ------------------------------------------------------------------------------------ Email: info@omrglobal.com Phone: +91 780-304-0404, +1 646-755-7667 Rising in the diabetic population is creating demand for diagnosis is driving the demand Indian Diabetes Diagnosis and Therapeutics Market. According to the International Disease Foundation, around 73 million people in India are suffering from diabetes. According to the WHO, it is expected that India will go pass China by 2030 both in terms of population and diabetic population. Furthermore, the market for drugs and diagnosis is boosting the country that is providing a lucrative opportunity for healthcare companies. Additionally, increasing obesity level, rising trend of wearable devices and the development of new products for the treatment and diagnosis of diabetes are the other factors that are supporting the growth of the market.

2. Browse the full report description of "Indian Diabetes Diagnosis and Therapeutics Market, by Disease Type (Type 1 Diabetes, Type 2 Diabetes, Gestational), By Drug Type (Oral anti-diabetic Drugs, Non- Insulin Injectable drugs, Combination Drugs), by Device Type (Blood Glucose Monitoring Devices, Blood Glucose Strips, Insulin devices, Others) - Global Trends, Size, Share, Growth, Industry Analysis and Forecast, 2019-2025" at https://www.omrglobal.com/industry-reports/indian-diabetes-market New product launches in the market The companies are launching new products and solution in the market for obtaining a sustainable position in the Indian diabetes market. For instance, in April 2019, Glenmark launches an anti-diabetes drug Remogliflozin in India and it is the first company globally to launch Remogliflozin and India is the first country to get access for this drug. It is innovative and patent-protected sodium glucoseco-transporter-2 (SGLT2) inhibitors that indicate in adults in the treatment of type-2 diabetes mellitus. SGLT2 inhibitors are classes of oral anti-diabetes drugs that administer induce weight, reduce cardiovascular risks and glycemic control. These types of product launch offer sustainable growth in the market. Trends in Indian diabetes diagnosis and therapeutics market With the increase in Indian diabetic population, government institutions and pharmaceutical companies concentrating majorly on developing innovative products that propels the Indian diabetes market. Integration of the healthcare sector and information technology has led to the development of innovative products. Major market players such as Merck and Sanofi are at the forefront of innovations. Numerous research programs are being conducted across the globe with the aim to provide accurate as well as technologically advanced solution, for the monitoring & management of diabetes. Moreover, innovative products such as smart insulin have gained major attraction in the Indian market. Visit here to know more about Indian Diabetes Diagnosis and Treatment Market study https://www.omrglobal.com/industry-reports/indian-diabetes-market Development of Artificial Pancreas Artificial pancreas technology is the next step in integrating insulin delivery systems and glucose monitors. US FDA and Juvenile Diabetes Research Foundation are working with continuous glucose monitors (CGMS) manufacturers to develop APD (Artificial Pancreas Devices). The FDA has laid down the guidelines for the design, use, safety, and shelf life of APD. The guidelines are aimed at increasing the pace of APD development to initiate the pre-market approval process. In March 2017, a new project on the development of artificial pancreas for closed loop blood glucose control of type-1 diabetic patients are initiated with the support of the Indian Council of Medical Research. The main aim of this project is to develop an effective artificial pancreas prototype for Type-1 diabetic patients.

3. Indian Diabetes Diagnosis and Treatment Market – Segmentation By Disease Type •Type 1 Diabetes •Type 2 Diabetes •Gestational By Drug Type •Oral anti-diabetic Drugs •Non-Insulin Injectable drugs •Combination Drugs By Device Type •Blood Glucose Monitoring Devices •Blood Glucose Strips •Insulin devices •Others (Lancets) To know more information, please request a free report sample https://www.omrglobal.com/request- sample/indian-diabetes-market Indian Diabetes Diagnosis and Treatment Market – Segment by Region North America •US •Canada Europe •Germany •UK •France •Spain •Italy •Rest of Europe

4. Asia-Pacific •China •India •Japan •Rest of Asia-Pacific Rest of the World •Middle East & Africa •Latin America About Orion Market Research OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404 Source: Indian Diabetes Diagnosis and Treatment Market